Cargando…
Gaussian field-based 3D-QSAR and molecular simulation studies to design potent pyrimidine–sulfonamide hybrids as selective BRAF(V600E) inhibitors
The “RAS-RAF-MEK-ERK” pathway is an important signaling pathway in melanoma. BRAF(V600E) (70–90%) is the most common mutation in this pathway. BRAF inhibitors have four types of conformers: type I (αC-IN/DFG-IN), type II (αC-IN/DFG-OUT), type I(1/2) (αC-OUT/DFG-IN), and type I/II (αC-OUT/DFG-OUT). F...
Autores principales: | Singh, Ankit Kumar, Novak, Jurica, Kumar, Adarsh, Singh, Harshwardhan, Thareja, Suresh, Pathak, Prateek, Grishina, Maria, Verma, Amita, Yadav, Jagat Pal, Khalilullah, Habibullah, Pathania, Vikas, Nandanwar, Hemraj, Jaremko, Mariusz, Emwas, Abdul-Hamid, Kumar, Pradeep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585928/ https://www.ncbi.nlm.nih.gov/pubmed/36329938 http://dx.doi.org/10.1039/d2ra05751d |
Ejemplares similares
-
Concept of Hybrid Drugs and Recent Advancements in Anticancer Hybrids
por: Singh, Ankit Kumar, et al.
Publicado: (2022) -
Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
por: Kumar, Adarsh, et al.
Publicado: (2023) -
Challenges and Opportunities in the Crusade of BRAF
Inhibitors: From 2002 to 2022
por: Singh, Ankit Kumar, et al.
Publicado: (2023) -
Medicinal chemistry perspective of pyrido[2,3-d]pyrimidines as anticancer agents
por: Kumar, Adarsh, et al.
Publicado: (2023) -
Guava Leaf Essential Oil as a Potent Antioxidant and Anticancer Agent: Validated through Experimental and Computational Study
por: Mandal, Ashok Kumar, et al.
Publicado: (2022)